MTAs – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

CCG > Outreach activities > Collaborations > MTAs

MTAs

2017

  • Matthew DeLisa, Cornell University, USA
  • Lance Wells, Complex Carbohydrate Research Center, University of Georgia, USA
  • Bluebird Bio, USA
  • Peng Wu, The Scripps Research Institute, USA
  • Mariana Nuti, University Sapienza of Rome, Italy
  • Thomas Caffrey, University of Nebraska Medical Center, USA

2016

  • Jean-Baptiste Gibier, INSERM, France
  • Alice Yu, Chang Gung Memorial Hospital, Taiwan
  • Michael Hollingsworth, University of Nebraska Medical Center, USA
  • James C. Paulson, The Scripps Research Institute, USA
  • Baburaj Kunnummal, Thermo Fisher Scientific, USA
  • Mariana Nuti, Laboratory of Tumor Immunology and Cell Therapy, Sapienza University of Rome, Italy 
  • Mads Daugaard, Vancouver Prostate Centre, University of British Columbia, Canada 
  • Paul Resnick, MabVax Therapeutics Holdings, Inc, USA 
  • Paolo Patri, Chiesi Farmaceutici S.p.A, Italy 
  • James Binley, San Diego Biomedical Research Institute, USA 
  • Adam Linstedt, Carnegie Mellon University, USA 
  • Daniel Rader, University of Pennsylvania, USA

2015

  • Stine Falsig Pedersen, University of Copenhagen, Denmark
  • Bent Winding Deleuran, Aarhus University, Denmark
  • Coriell Institute, USA
  • Fillipo Mulinacci, Hoffmann-La Roche Ltd. Switzerland
  • Gerrit Wolters, University Hamburg, Germany
  • Patric van Berke, ADC Therapeutics Sárl, Switzerland
  • Galecto Biotech AB, Denmark
  • Ulla Petäjä-Repo, University of Oulu, Finland
  • Zymenex, Denmark
  • INSERM, France
  • Xuefei Huang, University of Michigan, USA
  • Yo-ichi Nabeshima, Kobe, Japan
  • Sai Kiran Sharma, Memorial Sloan Kettering Cancer Center, USA
  • Brian L. Schmidt, University of New York, USA
  • Francis Jacob, University of Basel, Switzerland

2014

  • Ulla Petäjä-Repo, University of Oulu, Finland
  • Jennifer Kohler, University of Texas, USA
  • Lawrence Shapiro, Columbia University, USA
  • John Babcook,The Centre for Drug Research and Development, Canada
  • Tom Curran, Children's Hospital of Philadelphia, USA
  • Lawrence Tabak, NIH/NIDCR, USA
  • Sandra Gendler, Mayo Clinic, Arizona
  • Søren Riis Paludan, Aarhus University, Denmark
  • Hans Schreiber, University of Chicago, USA
  • Rosa Di Paola, IRCCS San Giovanni Rotondo, Italy
  • Michael Hollingsworth, University of Nebraska, USA
  • Chiara DeNatale, Addgene, USA
  • Nabil G. Seidah, Laboratory of Biochemical Neuroendocrinology, Canada
  • Kristina Nyström, Sahlgrenska University Hospital, Sweden
  • Julia Maxson, Fred Hutchinson Cancer Center, USA
  • Malene Vester-Christensen, Novo Nordisk, Denmark
  • Euroscreen, Belgium
  • Chris Overall, University of British Columbia, Canada

2013

  • Hakon Leffler, Lund University, Sweden
  • Amgen, USA
  • Otsuka Pharmaceutical, Japan
  • Thermo Fisher Scientific, USA
  • Thermo Fisher Scientific, Germany
  • R. Hughe, University of Pittsburgh, USA
  • Richard Cummings, Emory University, USA
  • Michael Hollingsworth, University of Nebraska, USA
  • Joy Burchell, King's College London, UK
  • Yashraj Biotechnology, Ltd., India
  • Novo Nordisk A/S, Denmark
  • Ray Owens, University of Oxford, UK
  • Leonor David, IPATIMUP, Portugal
  • Celso Reis, IPATIMUP, Portugal
  • Novo Nordisk Denmark
  • Gunnar Hansson, University of Gothenburg, Sweden
  • Thomas Gerken, Case Western University, USA
  • Frederic Bard, STAR, Singapore
  • Mariana Nuti, Laboratory of Tumor Immunology and Cell Therapy, Sapienza University of Rome, Italy 

2012

  • Hans Schreiber, University of Chicago, USA
  • Novo Nordisk Center for Biosustainability, DTU
  • ALK-Abello A/S
  • Sigma-Aldrich, USA
  • Adam Linstedt, Carnegie Mellon University, USA
  • Mustafa Khokha, Yale University, USA
  • Tommy Nilsson, McGill University, Canada
  • Daniel Radar, University of Pennsylvania, USA
  • Nabil Seidah, Institut de recherches cliniques de Montréal, Canada
  • Tatsuro Irimura, University of Tokyo, Japan
  • Ramesh Ragupathi, Memorial Sloan-Kettering Cancer Center, USA